$ADTX News ~ Aditxt’s Subsidiary, Pearsanta, Inc. Engages Spartan Capital as Lead Underwriter for its Planned IPO Intending to Drive Clinical Validation and Commercial Rollout of Its Mitomic™ Platform Technology for Early Detection of Cancers and Other Diseases
Planned IPO Aligns with Aditxt’s Acquire, Build and Capitalize (ABC) Monetization Framework